Selected research
Market Structure
Global Loratadine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Loratadine API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Loratadine API include Shenzhen Salubris Pharmaceuticals, Shenzhen Haibin Pharmaceutical, Merck Group, Mylan, Shaanxi Hanjiang, Changzhou Yabang, Changzhou Fangyuan Pharmaceutical, Vasudha Pharma Chem and Ultratech India Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Loratadine API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Loratadine API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Loratadine API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Loratadine API market size, projected growth trends, production technologies, key applications, and end-use industries.
Loratadine API Segment by Company
Shenzhen Salubris Pharmaceuticals
Shenzhen Haibin Pharmaceutical
Merck Group
Mylan
Shaanxi Hanjiang
Changzhou Yabang
Changzhou Fangyuan Pharmaceutical
Vasudha Pharma Chem
Ultratech India Limited
Morepen
Inke, S.A.
Hetero Drugs Ltd
Cadila Pharmaceuticals
Argon Drugs
Loratadine API Segment by Type
Pharmaceutical Standards Grade
EP Standards Grade
USP Standards Grade
Others
Loratadine API Segment by Application
Loratadine Syrup
Loratadine Tablet
Loratadine Capsules
Dry Suspension
Others
Loratadine API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Loratadine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Loratadine API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Loratadine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Loratadine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Loratadine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Standards Grade
- EP Standards Grade
- USP Standards Grade
- Others
Applications
- Loratadine Syrup
- Loratadine Tablet
- Loratadine Capsules
- Dry Suspension
- Others
Companies covered
- Shenzhen Salubris Pharmaceuticals
- Shenzhen Haibin Pharmaceutical
- Merck Group
- Mylan
- Shaanxi Hanjiang
- Changzhou Yabang
- Changzhou Fangyuan Pharmaceutical
- Vasudha Pharma Chem
- Ultratech India Limited
- Morepen
- Inke, S.A.
- Hetero Drugs Ltd
- Cadila Pharmaceuticals
- Argon Drugs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Loratadine API Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Loratadine API Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Loratadine API Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Loratadine API Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Loratadine API Market Dynamics
- 2.1 Loratadine API Industry Trends
- 2.2 Loratadine API Industry Drivers
- 2.3 Loratadine API Industry Opportunities and Challenges
- 2.4 Loratadine API Industry Restraints
3 Loratadine API Market by Manufacturers
- 3.1 Global Loratadine API Revenue by Manufacturers (2021-2026)
- 3.2 Global Loratadine API Sales by Manufacturers (2021-2026)
- 3.3 Global Loratadine API Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Loratadine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Loratadine API Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Loratadine API Manufacturers, Product Type & Application
- 3.7 Global Loratadine API Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Loratadine API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Loratadine API Players Market Share by Revenue in 2025
- 3.8.3 2025 Loratadine API Tier 1, Tier 2, and Tier 3
4 Loratadine API Market by Type
- 4.1 Loratadine API Type Introduction
- 4.1.1 Pharmaceutical Standards Grade
- 4.1.2 EP Standards Grade
- 4.1.3 USP Standards Grade
- 4.1.4 Others
- 4.2 Global Loratadine API Sales by Type
- 4.2.1 Global Loratadine API Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Loratadine API Sales by Type (2021-2032)
- 4.2.3 Global Loratadine API Sales Market Share by Type (2021-2032)
- 4.3 Global Loratadine API Revenue by Type
- 4.3.1 Global Loratadine API Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Loratadine API Revenue by Type (2021-2032)
- 4.3.3 Global Loratadine API Revenue Market Share by Type (2021-2032)
5 Loratadine API Market by Application
- 5.1 Loratadine API Application Introduction
- 5.1.1 Loratadine Syrup
- 5.1.2 Loratadine Tablet
- 5.1.3 Loratadine Capsules
- 5.1.4 Dry Suspension
- 5.1.5 Others
- 5.2 Global Loratadine API Sales by Application
- 5.2.1 Global Loratadine API Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Loratadine API Sales by Application (2021-2032)
- 5.2.3 Global Loratadine API Sales Market Share by Application (2021-2032)
- 5.3 Global Loratadine API Revenue by Application
- 5.3.1 Global Loratadine API Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Loratadine API Revenue by Application (2021-2032)
- 5.3.3 Global Loratadine API Revenue Market Share by Application (2021-2032)
6 Global Loratadine API Sales by Region
- 6.1 Global Loratadine API Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Loratadine API Sales by Region (2021-2032)
- 6.2.1 Global Loratadine API Sales by Region (2021-2026)
- 6.2.2 Global Loratadine API Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Loratadine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Loratadine API Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Loratadine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Loratadine API Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Loratadine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Loratadine API Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Loratadine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Loratadine API Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Loratadine API Revenue by Region
- 7.1 Global Loratadine API Revenue by Region
- 7.1.1 Global Loratadine API Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Loratadine API Revenue by Region (2021-2026)
- 7.1.3 Global Loratadine API Revenue by Region (2027-2032)
- 7.1.4 Global Loratadine API Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Loratadine API Revenue (2021-2032)
- 7.2.2 North America Loratadine API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Loratadine API Revenue (2021-2032)
- 7.3.2 Europe Loratadine API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Loratadine API Revenue (2021-2032)
- 7.4.2 Asia-Pacific Loratadine API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Loratadine API Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Loratadine API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Shenzhen Salubris Pharmaceuticals
- 8.1.1 Shenzhen Salubris Pharmaceuticals Company Information
- 8.1.2 Shenzhen Salubris Pharmaceuticals Business Overview
- 8.1.3 Shenzhen Salubris Pharmaceuticals Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Shenzhen Salubris Pharmaceuticals Loratadine API Product Portfolio
- 8.1.5 Shenzhen Salubris Pharmaceuticals Recent Developments
- 8.2 Shenzhen Haibin Pharmaceutical
- 8.2.1 Shenzhen Haibin Pharmaceutical Company Information
- 8.2.2 Shenzhen Haibin Pharmaceutical Business Overview
- 8.2.3 Shenzhen Haibin Pharmaceutical Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shenzhen Haibin Pharmaceutical Loratadine API Product Portfolio
- 8.2.5 Shenzhen Haibin Pharmaceutical Recent Developments
- 8.3 Merck Group
- 8.3.1 Merck Group Company Information
- 8.3.2 Merck Group Business Overview
- 8.3.3 Merck Group Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck Group Loratadine API Product Portfolio
- 8.3.5 Merck Group Recent Developments
- 8.4 Mylan
- 8.4.1 Mylan Company Information
- 8.4.2 Mylan Business Overview
- 8.4.3 Mylan Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Mylan Loratadine API Product Portfolio
- 8.4.5 Mylan Recent Developments
- 8.5 Shaanxi Hanjiang
- 8.5.1 Shaanxi Hanjiang Company Information
- 8.5.2 Shaanxi Hanjiang Business Overview
- 8.5.3 Shaanxi Hanjiang Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Shaanxi Hanjiang Loratadine API Product Portfolio
- 8.5.5 Shaanxi Hanjiang Recent Developments
- 8.6 Changzhou Yabang
- 8.6.1 Changzhou Yabang Company Information
- 8.6.2 Changzhou Yabang Business Overview
- 8.6.3 Changzhou Yabang Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Changzhou Yabang Loratadine API Product Portfolio
- 8.6.5 Changzhou Yabang Recent Developments
- 8.7 Changzhou Fangyuan Pharmaceutical
- 8.7.1 Changzhou Fangyuan Pharmaceutical Company Information
- 8.7.2 Changzhou Fangyuan Pharmaceutical Business Overview
- 8.7.3 Changzhou Fangyuan Pharmaceutical Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Changzhou Fangyuan Pharmaceutical Loratadine API Product Portfolio
- 8.7.5 Changzhou Fangyuan Pharmaceutical Recent Developments
- 8.8 Vasudha Pharma Chem
- 8.8.1 Vasudha Pharma Chem Company Information
- 8.8.2 Vasudha Pharma Chem Business Overview
- 8.8.3 Vasudha Pharma Chem Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Vasudha Pharma Chem Loratadine API Product Portfolio
- 8.8.5 Vasudha Pharma Chem Recent Developments
- 8.9 Ultratech India Limited
- 8.9.1 Ultratech India Limited Company Information
- 8.9.2 Ultratech India Limited Business Overview
- 8.9.3 Ultratech India Limited Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Ultratech India Limited Loratadine API Product Portfolio
- 8.9.5 Ultratech India Limited Recent Developments
- 8.10 Morepen
- 8.10.1 Morepen Company Information
- 8.10.2 Morepen Business Overview
- 8.10.3 Morepen Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Morepen Loratadine API Product Portfolio
- 8.10.5 Morepen Recent Developments
- 8.11 Inke, S.A.
- 8.11.1 Inke, S.A. Company Information
- 8.11.2 Inke, S.A. Business Overview
- 8.11.3 Inke, S.A. Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Inke, S.A. Loratadine API Product Portfolio
- 8.11.5 Inke, S.A. Recent Developments
- 8.12 Hetero Drugs Ltd
- 8.12.1 Hetero Drugs Ltd Company Information
- 8.12.2 Hetero Drugs Ltd Business Overview
- 8.12.3 Hetero Drugs Ltd Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Hetero Drugs Ltd Loratadine API Product Portfolio
- 8.12.5 Hetero Drugs Ltd Recent Developments
- 8.13 Cadila Pharmaceuticals
- 8.13.1 Cadila Pharmaceuticals Company Information
- 8.13.2 Cadila Pharmaceuticals Business Overview
- 8.13.3 Cadila Pharmaceuticals Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Cadila Pharmaceuticals Loratadine API Product Portfolio
- 8.13.5 Cadila Pharmaceuticals Recent Developments
- 8.14 Argon Drugs
- 8.14.1 Argon Drugs Company Information
- 8.14.2 Argon Drugs Business Overview
- 8.14.3 Argon Drugs Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Argon Drugs Loratadine API Product Portfolio
- 8.14.5 Argon Drugs Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Loratadine API Value Chain Analysis
- 9.1.1 Loratadine API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Loratadine API Production Mode & Process
- 9.2 Loratadine API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Loratadine API Distributors
- 9.2.3 Loratadine API Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst